A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase 2 Study to Evaluate the Efficacy and Safety of CU104 in Patients With Moderate to Severe Ulcerative Colitis
The study is designed to investigate efficacy and safety of CU104 in patients with moderate to severe ulcerative colitis.